Educational protocol hub
CJC-1295 (No DAC) / Mod GRF 1-29: protocol variants and reconstitution resources
Educational hub for CJC-1295 (No DAC) / Mod GRF 1-29, grouping 2 available protocol variants with links to the exact dosage and reconstitution pages.
What this hub covers
This page groups the available CJC-1295 (No DAC) / Mod GRF 1-29 protocol variants so readers can choose the exact vial-size guide without mixing formats.
Reconstitution workflow
Use the linked protocol pages and calculator resources to review concentration, diluent logic and unit conversions for the selected variant.
Research-only context
All information is educational and literature-focused. AllPeptides.eu does not sell peptides and does not provide medical advice.
Available protocol variants
Choose the exact guide you want to view.
CJC-1295 (No DAC) / Mod GRF 1-29
CJC-1295 without DAC (known as Mod GRF 1-29) is a modified GHRH analog with a half-life of ~30 minutes, often used in combination with GHRP peptides. Research sources report subcutaneous administration of 100 mcg to 300 mcg, once daily, at bedtime, increased gradually.
View protocolCJC-1295 NO DAC
CJC-1295 NO DAC dosing protocols utilize this synthetic 29-amino acid GHRH analog (also known as Modified GRF 1–29 or Mod GRF) to stimulate natural, pulsatile growth hormone secretion from the pituitary gland. Unlike exogenous GH, it preserves the physiological feedback loop, supporting enhanced GH and IGF‑1 levels with natural hormonal rhythms. Research sources report subcutaneous administration of 100 mcg to 300 mcg, once daily, at bedtime, increased gradually.
View protocolRelated research resources
Internal links that help readers and search engines understand this peptide topic cluster.
References
- Teichman SL et al. J Clin Endocrinol Metab 2006 — Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults.
View Source - Modified GRF (1–29): Structure, Substitutions, Pharmacokinetics — Wikipedia — Modified GRF (1–29): structure, substitutions, pharmacokinetics
View Source - CJC-1295 Normalizes Growth in GHRH KO Mice — Am J Physiol (2006) — CJC-1295 normalizes growth in GHRH KO mice
View Source - Sermorelin: Improved Management of Adult GH Deficiency (PMC) — Sermorelin: improved management of adult GH deficiency
View Source - Safety and Efficacy of GH Secretagogues — Review (PMC) — Safety and efficacy of growth hormone secretagogues
View Source
Educational and laboratory research information only. AllPeptides.eu does not sell peptides and does not provide medical advice or human-use instructions.